Keudell/Morrison Wealth Management
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1785498
Salem, OR
Position in VRTX
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$303,998
+$30,716 QoQ
Shares Held
612
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,230
of 1,735 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Keudell/Morrison Wealth Management holds $2,313,445 across 6 Biotechnology names. VRTX ranks #5 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KYMR |
Kymera Therapeutics, Inc.
|
5,215 | $598,004 | |
| 2 | ARGX |
Argenx SE
|
506 | $469,451 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
582 | $362,900 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,359 | $327,478 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
612 | $303,998 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
6,450 | $251,614 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $303,998 | 612 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $273,282 | 612 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $277,456 | 612 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $265,784 | 597 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $311,254 | 642 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $260,144 | 646 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $300,441 | 646 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $436,378 | 931 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $413,829 | 990 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $406,890 | 1,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $365,127 | 1,050 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $386,045 | 1,097 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $382,810 | 1,215 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $315,347 | 1,092 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $350,053 | 1,209 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $380,980 | 1,352 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $375,274 | 1,438 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $304,146 | 1,385 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $306,186 | 1,688 | Shares | Sole | 2021-12-08 | |
| 2021-06-30 | $348,618 | 1,729 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $361,230 | 1,681 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $391,379 | 1,656 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $383,417 | 1,409 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $364,048 | 1,254 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $210,585 | 885 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||